|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Arch Therapeutics, Inc. (ARTH) |
|
|
$0.03 0.00 (0.00%) as of 4:30 Tue 1/17
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
149,943,000 |
| Market
Cap: |
4.80(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.032 - $0.032 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arch Therapeutics is a biotechnology company marketing or developing a number of products based on its AC5® self-assembling technology platform. Co.'s product candidates are derived from its AC5 self-assembling peptide technology platform and are referred to as AC5®. These include AC5® Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include, for example, AC5-G™ for gastrointestinal endoscopic procedures and AC5-V® and AC5® Surgical Hemostat for hemostasis inside the body.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
27,446 |
27,446 |
| Total Buy Value |
$0 |
$0 |
$7,547 |
$7,547 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hicks Laurence |
Director |
• • – |
2023-08-31 |
4 |
B |
$0.28 |
$2,830 |
I/I |
10,292 |
10,292 |
2.1 |
- |
|
| Abrams Michael S |
CHIEF FINANCIAL OFFICER |
• • – |
2023-08-31 |
4 |
B |
$0.28 |
$2,830 |
D/D |
10,292 |
10,292 |
2.66 |
- |
|
| Norchi Terrence W |
PRESIDENT AND CHIEF EXECUTIVE |
• • – |
2023-08-31 |
4 |
B |
$0.28 |
$1,887 |
D/D |
6,862 |
6,862 |
2.73 |
- |
|
| Abrams Michael S |
CHIEF FINANCIAL OFFICER |
• – – |
2022-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
108,652 |
108,652 |
|
- |
|
| Norchi Terrence W |
PRESIDENT AND CHIEF EXECUTIVE |
• – – |
2022-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
72,435 |
2,981,512 |
|
- |
|
| Hicks Laurence |
|
– • – |
2022-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
108,652 |
108,652 |
|
- |
|
| Hicks Laurence |
Director |
– • – |
2021-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,273 |
|
17% |
|
| Yrigoyen Dan |
Vice President, Sales |
• – – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
|
- |
|
| Sulat James R |
Director |
– • – |
2020-06-22 |
4 |
A |
$81,818.30 |
$2,147,483,647 |
I/I |
454,546 |
1,376,813 |
|
- |
|
| Davis Richard E |
CFO & Treasurer |
• – – |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
275,000 |
878,000 |
|
- |
|
| Sulat James R |
Director |
– • – |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
110,000 |
370,000 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
220,000 |
8,517,373 |
|
- |
|
| Norchi Terrence W |
President & CEO |
• • • |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
360,000 |
3,559,076 |
|
- |
|
| Sulat James R |
Director |
– • – |
2018-07-16 |
4 |
OE |
$0.37 |
$11,100 |
D/D |
30,000 |
260,000 |
|
- |
|
| Sulat James R |
Director |
– • – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
230,000 |
|
- |
|
| Davis Richard E |
CFO & Treasurer |
• – – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
603,000 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
8,297,373 |
|
- |
|
| Norchi Terrence W |
President & CEO |
• • • |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
650,000 |
3,199,076 |
|
- |
|
| Sulat James R |
Director |
– • – |
2016-05-26 |
4 |
B |
$0.00 |
$0 |
I/I |
111,111 |
868,934 |
2.02 |
- |
|
| Norchi Terrence W |
President & CEO |
• • • |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,130,000 |
2,549,076 |
|
- |
|
| Davis Richard E |
CFO & Treasurer |
• – – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
103,000 |
103,000 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
737,000 |
7,897,373 |
|
- |
|
| Sulat James R |
Director |
– • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Sulat James R |
Director |
– • – |
2015-08-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
727,823 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
